BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Eurobiomed - ECPv6.10.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Eurobiomed
X-ORIGINAL-URL:https://www.eurobiomed.org
X-WR-CALDESC:Évènements pour Eurobiomed
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220512T084500
DTEND;TZID=Europe/Paris:20220512T163000
DTSTAMP:20260406T073547
CREATED:20211202T110635Z
LAST-MODIFIED:20240607T072510Z
UID:6829-1652345100-1652373000@www.eurobiomed.org
SUMMARY:Rencontre Thématique Oncology : Horizon 2030
DESCRIPTION:Oncology : Horizon 2030\nTechnologies and models to address tumor heterogeneity for better personalized medicine\n \nEurobiomed Cluster invites you to its next thematic meeting dedicated to oncology\, in partnership with the Occitanie Region\, Ad’occ and Toulouse Métropole. This day will address the prospects in oncology by 2030. More specifically\, it will focus on innovations in precision medicine and heterogeneity of tumors\, themes opening up prospects for more personalized medicine for better patient care. \nProgram \n8:45 : Welcome\n9:15 : Opening \n\nMichael DANON – President of Eurobiomed\nVincent BOUNES\, Vice President of Occitanie Region in charge of health\nPatricia BEZ\, Deputy Major of Toulouse Metropole in charge of Health\n\n9:40 : Glioblastoma : an example of tumor heterogeneity and a major medical challenge \nPr Elizabeth MOYAL – Neuro-oncologist and Head of the radiotherapy department – Institut Universitaire du Cancer – Toulouse Oncopole \n10:05 : Current scientific and industrial approaches to address tumor heterogeneity and microenvironment – 1st session \n\nMultimodal single cell omics : a technological revolution for fundamental and clinical oncology\nJean-Jacques FOURNIE\, Centre de Recherche en Cancérologie de Toulouse\nComputational biology approaches to characterise and model the tumour microenvironment\nVera PANCALDI\, Centre de Recherche en Cancérologie de Toulouse\nDevelopment of NIK modulators for cancer treatment\nArnaud FOUSSAT\, CEO Yukin Therapeutics\n\n11:15 : Coffee Break \n11:35 : Current scientific and industrial approaches to address tumor heterogeneity and microenvironment – 2nd session \n\nRole of stromal heterogeneity in immunosuppression and resistance to immunotherapy in cancer\nFatima MECHTA-GRIGORIOU\, Institut Curie (by videoconference)\nHarnessing innate immunity in cancer therapy\nAriane MOREL\, Director R&D – Pharmacology Department\, Innate Pharma\n\n12:20 : High-plex tissue imaging: an integrative way to analyze tumor microenvironment contexture and spatial heterogeneity\nAïda MEGHRAOUI-KHEDDAR\, CEO AMKbiotech \n12:25 : Lunch \n14:00 : Current scientific and industrial approaches to address tumor heterogeneity and microenvironment – 3rd session \n\nProtein glycosylation and cellular interfaces in cancer biology\nFrédéric BARD\, Centre de Recherche en Cancérologie de Marseille\nWhat is neutrophil homeostasis telling us on immune checkpoint blockade in NSCLC?\nJulien FAGET\, Institut de Recherche en Cancérologie de Montpellier\nHigh endothelial venules (HEVs): specialized blood vessels for lymphocyte entry into tumors during cancer immunotherapy\nJean-Philippe GIRARD\, Institut de Pharmacologie et de Biologie Structurale de Toulouse\nDiag2tec’s tools and models to study the response to new therapeutic agents in hematological malignancies\nDjamila CHEMLAL \, PhD Student Diag2tec\nMicrobiomes contribute to tumor microenvironment\, progression and treatment responsiveness\nCéline RIBIERE\, Microbiome Scientist Vaiomer\n\n15:55 : Oncology at Pierre Fabre – A strategic perspective\nFrancesco HOFMANN Medical Care R&D Director \n16:20 : Closing by Eurobiomed\n16:25 : End of the event \nInformation : Leïla TOUIHRI \nRegister on line here \n  \nEvent sponsored by \n \n  \nWith the support of the scientific committee
URL:https://www.eurobiomed.org/evenement/rencontre-thematique-oncologie-horizon-2030/
CATEGORIES:Rencontre thématique
ATTACH;FMTTYPE=:
END:VEVENT
END:VCALENDAR